Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid Tests for Chagas Disease Improves Diagnostic Access

By LabMedica International staff writers
Posted on 08 Jul 2025

Chagas disease, caused by the parasite Trypanosoma cruzi, affects between six and seven million people across the Americas. More...

It is primarily transmitted by insect vectors and remains largely underdiagnosed, with less than 1% of those infected receiving treatment. The disease is most commonly diagnosed through serological techniques, which detect antibodies to T. cruzi in the blood during the chronic phase of the disease. However, these methods require specialized personnel and equipment, which are often unavailable in resource-limited areas, making it difficult for people in endemic regions to access proper diagnosis and care. A new approach, combining rapid diagnostic tests (RDTs) with conventional serological techniques, has been proposed to improve access to diagnosis in such settings.

Researchers at the Barcelona Institute for Global Health (ISGlobal, Barcelona, Spain), in collaboration with Paraguayan health authorities, conducted a study involving a screening campaign in an indigenous community in the Paraguayan Chaco, where 999 people were tested. The researchers evaluated the effectiveness of using RDTs for initial screening, followed by confirmation with conventional serological tests such as recombinant and lysate ELISA. The combination of these two methods was found to be highly effective, providing an accessible and rapid solution for diagnosing Chagas disease in remote areas.

The study, published in PLOS Neglected Tropical Diseases, demonstrated that the algorithm using RDTs showed high agreement with the standard algorithm, with a sensitivity of 94.6% and a specificity of 98.6%. The algorithm validated in the study suggests using RDTs for an initial screening of at-risk individuals in endemic areas, thereby reducing the need for serological testing to confirm positive results. The prevalence of the disease was found to be significantly higher in the indigenous community of Casanillo compared to the capital, Asunción, highlighting the health inequalities in urban and rural areas. The researchers plan to further evaluate this approach in other regions and adapt it for broader use in endemic areas to improve access to diagnosis and treatment.

“The results obtained are particularly relevant in the context of a global re-evaluation of guidelines for the diagnosis and treatment of Chagas disease,” said Irene Losada, coordinator of the Chagas Initiative at ISGlobal and senior author of the study. “The adoption of RDT-based algorithms adapted to each region could improve access to diagnosis for thousands of people in remote areas.”

Related Links:
ISGlobal


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.